BSE 524372

Orchid Pharma Board Approves ₹600 Crore Fundraise for Strategic Growth

Orchid Pharma Ltd's board has approved an enabling resolution to raise up to ₹600 crore through equity or debt, representing 11.2% of its current market cap.

Orchid Pharma · 20 Oct 2026, 12:14 PM IST